The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 09, 2020

Filed:

Aug. 08, 2015
Applicant:

Zhejiang Jiuzhou Pharmaceutical Co., Ltd, Taizhou, CN;

Inventors:

Qilin Zhou, Tianjin, CN;

Jianhua Xie, Tianjin, CN;

Xiaohui Yang, Tianjin, CN;

Lixin Wang, Tianjin, CN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 69/675 (2006.01); C07C 29/149 (2006.01); C07C 31/20 (2006.01); C07C 67/48 (2006.01); B01J 31/18 (2006.01); B01J 31/24 (2006.01); C07B 53/00 (2006.01); C07B 57/00 (2006.01); C07D 211/02 (2006.01); C07D 211/12 (2006.01); C07D 305/06 (2006.01); C07D 309/06 (2006.01); C07D 473/06 (2006.01); C07D 309/30 (2006.01); C07C 69/732 (2006.01); C07C 69/708 (2006.01); C07C 33/26 (2006.01);
U.S. Cl.
CPC ...
C07C 69/675 (2013.01); B01J 31/181 (2013.01); B01J 31/189 (2013.01); B01J 31/249 (2013.01); C07B 53/00 (2013.01); C07B 57/00 (2013.01); C07C 29/149 (2013.01); C07C 31/20 (2013.01); C07C 67/48 (2013.01); C07D 211/02 (2013.01); C07D 211/12 (2013.01); C07D 305/06 (2013.01); C07D 309/06 (2013.01); C07D 473/06 (2013.01); B01J 31/24 (2013.01); B01J 2231/646 (2013.01); B01J 2531/827 (2013.01); C07B 2200/07 (2013.01); C07C 33/26 (2013.01); C07C 69/708 (2013.01); C07C 69/732 (2013.01); C07D 309/30 (2013.01);
Abstract

The present invention relates to kinetic resolution of racemic δ-hydroxyl ester via asymmetric catalytic hydrogenation and an application thereof. In the presence of chiral spiro pyridyl phosphine ligand Iridium catalyst and base, racemic δ-hydroxyl esters were subjected to asymmetric catalytic hydrogenation to obtain extent optical purity chiral δ-hydroxyl esters and corresponding 1,5-diols. An optically active chiral δ-hydroxyl ester and 1,5-diols can be obtained at very high enantioselectivity and yield with relatively low usage of catalyst. The chiral δ-hydroxyl ester and 1,5-diols obtained by using the method can be used as a critical raw material for asymmetric synthesis of chiral drugs (R)-lisofylline and natural drugs (+)-civet, (−)-indolizidine 167B and (−)-coniine.


Find Patent Forward Citations

Loading…